About this FactMed analysis covering adverse side effect reports of ALIZAPRIDE patients who developed FLATULENCE.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking ALIZAPRIDE reported FLATULENCE to the FDA. A total of 102 ALIZAPRIDE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALIZAPRIDE and FLATULENCE. In doing so, we compare ALIZAPRIDE with other drugs that cause FLATULENCE, to help you evaluate whether or not ALIZAPRIDE causes FLATULENCE. Likewise, this page shows the most highly-reported side effects of ALIZAPRIDE, so you can see if FLATULENCE ranks among ALIZAPRIDE's most well-known side effects.
Summary Statistics
Reports of ALIZAPRIDE causing FLATULENCE: 2
Reports of any side effect of ALIZAPRIDE : 102
Percentage of ALIZAPRIDE patients where FLATULENCE is a reported side effect: 1.9608%

FDA reports of any drug causing FLATULENCE : 14969
Average percentage for all medicated patients where FLATULENCE is reported as a complication: 0.0938%

Physician opinion on ALIZAPRIDE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALIZAPRIDE:
DRUG USE FOR UNKNOWN INDICATION ( 14 patients )
NAUSEA ( 14 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3 patients )
PREMEDICATION ( 2 patients )
VOMITING ( 2 patients )
ANTIEMETIC SUPPORTIVE CARE ( 2 patients )
PROPHYLAXIS ( 1 patients )
PROPHYLAXIS OF NAUSEA AND VOMITING ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with FLATULENCE:

CHANTIX (1937 patients)
ALLI (1493 patients)
ASPIRIN (1016 patients)
SANDOSTATIN LAR (1008 patients)
NEXIUM (974 patients)
LIPITOR (853 patients)
BYETTA (764 patients)
FOSAMAX (763 patients)
VIOXX (582 patients)
PRADAXA (530 patients)
SYNTHROID (505 patients)
LISINOPRIL (450 patients)
FORTEO (449 patients)
PRILOSEC (442 patients)
HUMIRA (417 patients)
OMEPRAZOLE (404 patients)
YAZ (395 patients)
ATENOLOL (390 patients)
CRESTOR (390 patients)
METFORMIN HCL (360 patients)
YASMIN (359 patients)
LASIX (357 patients)
LYRICA (357 patients)
XANAX (353 patients)
HYDROCHLOROTHIAZIDE (325 patients)
PLAVIX (318 patients)
PROTONIX (317 patients)
NEURONTIN (315 patients)
SIMVASTATIN (301 patients)
CYMBALTA (301 patients)
NORVASC (289 patients)
ZOLOFT (288 patients)
CALCIUM (286 patients)
FOLIC ACID (283 patients)
LEVOTHYROXINE SODIUM (276 patients)
TOPROL-XL (268 patients)
ZOCOR (267 patients)
CELEBREX (265 patients)
PREVACID (264 patients)
PREDNISONE (261 patients)
LEXAPRO (259 patients)
VITAMIN D (256 patients)
NIASPAN (255 patients)
VICTOZA (252 patients)
IBUPROFEN (245 patients)
GLUCOPHAGE (241 patients)
COUMADIN (237 patients)
AMBIEN (214 patients)
DIOVAN (213 patients)
FUROSEMIDE (212 patients)
ZETIA (209 patients)
ALBUTEROL (208 patients)
SEROQUEL (206 patients)
AVANDIA (201 patients)
ATIVAN (198 patients)
VICODIN (194 patients)
DIGOXIN (193 patients)
ALL OTHER THERAPEUTIC PRODUCTS (193 patients)
LANTUS (193 patients)
VITAMINS (183 patients)
LORAZEPAM (181 patients)
ASCORBIC ACID (181 patients)
ENBREL (180 patients)
ACCUTANE (177 patients)
NEXAVAR (177 patients)
MULTI-VITAMIN (177 patients)
METFORMIN (174 patients)
GABAPENTIN (173 patients)
FISH OIL (172 patients)
ADVAIR DISKUS 100/50 (169 patients)
BONIVA (168 patients)
OXYCONTIN (166 patients)
GLIPIZIDE (166 patients)
PREMARIN (164 patients)
EXJADE (162 patients)
ACETAMINOPHEN (162 patients)
SPIRIVA (161 patients)
ACTOS (157 patients)
ZELNORM (155 patients)
ALPRAZOLAM (155 patients)
CLONAZEPAM (155 patients)
ZOMETA (154 patients)
ACETYLSALICYLIC ACID (154 patients)
ACIPHEX (154 patients)
METHOTREXATE (153 patients)
POTASSIUM CHLORIDE (152 patients)
GLYBURIDE (151 patients)
METOPROLOL (151 patients)
ALLOPURINOL (150 patients)
COREG (148 patients)
METOPROLOL TARTRATE (147 patients)
MULTI-VITAMINS (146 patients)
PAXIL (146 patients)
AMLODIPINE (146 patients)
COZAAR (145 patients)
DROSPIRENONE AND ETHINYL ESTRADIOL (144 patients)
ZANTAC (144 patients)
EFFEXOR (143 patients)
LEVAQUIN (142 patients)
SINGULAIR (137 patients)
INSULIN (136 patients)
WELLBUTRIN (136 patients)
VITAMIN E (135 patients)
MORPHINE (135 patients)
COMMIT (134 patients)
WARFARIN SODIUM (132 patients)
AMARYL (130 patients)
VITAMIN B-12 (129 patients)
MIRALAX (127 patients)
PROZAC (124 patients)
TRAZODONE HCL (124 patients)
LOVAZA (123 patients)
KLONOPIN (121 patients)
TRAMADOL HCL (120 patients)
PERCOCET (119 patients)
ACTONEL (114 patients)
VYTORIN (113 patients)
NITROGLYCERIN (113 patients)
ZYRTEC (113 patients)
ALLEGRA (111 patients)
ALTACE (111 patients)
GLUCOSAMINE (111 patients)
EFFEXOR XR (110 patients)
CALCIUM CARBONATE (109 patients)
RANITIDINE (105 patients)
SPIRONOLACTONE (104 patients)
TYLENOL (103 patients)
GLEEVEC (101 patients)
LEVOXYL (101 patients)
TRICOR (101 patients)
OXYCODONE HCL (100 patients)
CHAMPIX (99 patients)
FLONASE (99 patients)
PREDNISONE TAB (97 patients)
JANUVIA (96 patients)
LANSOPRAZOLE (96 patients)
PRILOSEC OTC (95 patients)
ACETYLSALICYLIC ACID SRT (95 patients)
TOPAMAX (95 patients)
ALENDRONATE SODIUM (95 patients)
FLOMAX (95 patients)
PREDNISOLONE (95 patients)
CELEXA (94 patients)
SIMCOR (91 patients)
SUTENT (91 patients)
DIAZEPAM (90 patients)
SANDOSTATIN (87 patients)
EVISTA (87 patients)
MULTIVITAMIN (87 patients)
TYLENOL (CAPLET) (86 patients)
CIMZIA (86 patients)
CITALOPRAM HYDROBROMIDE (86 patients)
POTASSIUM (86 patients)
HUMALOG (86 patients)
BEXTRA (85 patients)
PEPCID (85 patients)
PANTOPRAZOLE (85 patients)
AREDIA (84 patients)
PRISTIQ (84 patients)
COMBIVENT (84 patients)
VALIUM (84 patients)
REVLIMID (83 patients)
NAPROXEN (82 patients)
ARIMIDEX (81 patients)
RAMIPRIL (81 patients)
CLARITIN (80 patients)
MOTRIN (79 patients)
LOPRESSOR (78 patients)
BENICAR (78 patients)
VERAPAMIL (77 patients)
HYDROCODONE (77 patients)
FLUOXETINE (77 patients)
MOBIC (77 patients)
ALEVE (CAPLET) (75 patients)
IRON (75 patients)
REMICADE (74 patients)
CIPROFLOXACIN (74 patients)
DILTIAZEM (73 patients)
REGLAN (73 patients)
ALEVE (73 patients)
ENALAPRIL MALEATE (73 patients)
AMOXICILLIN (73 patients)
ZANTAC 150 (72 patients)
CLONIDINE (72 patients)
FENTANYL (72 patients)
LAMICTAL (70 patients)
BENADRYL (70 patients)
VITAMIN TAB (69 patients)
WELLBUTRIN XL (69 patients)
ADVIL (69 patients)
PRAVASTATIN (68 patients)
PRAVACHOL (68 patients)
TYSABRI (68 patients)
METOCLOPRAMIDE (66 patients)
AVAPRO (66 patients)
LORTAB (66 patients)
BACLOFEN (66 patients)
ATACAND (66 patients)
ZOFRAN (66 patients)
KEPPRA (65 patients)
PAROXETINE HCL (65 patients)
VITAMIN B COMPLEX CAP (64 patients)
METAMUCIL-2 (64 patients)
SOMA (64 patients)
ZYPREXA (63 patients)
AMITRIPTYLINE HCL (63 patients)
SYMBICORT (63 patients)
AVELOX (62 patients)
GLUCOTROL (62 patients)
DILAUDID (62 patients)
Most common side effects for patients taking ALIZAPRIDE:
DIARRHOEA (16 patients)
PYREXIA (16 patients)
VOMITING (10 patients)
FATIGUE (9 patients)
HYPOKALAEMIA (9 patients)
DEHYDRATION (8 patients)
NAUSEA (7 patients)
ANAEMIA (6 patients)
ASTHENIA (6 patients)
BRONCHOPNEUMONIA (6 patients)
DRUG INTERACTION (6 patients)
DYSPNOEA (6 patients)
HYPOTENSION (6 patients)
PNEUMONIA (6 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (5 patients)
HAEMORRHAGE (5 patients)
HYPOMAGNESAEMIA (5 patients)
HYPOPHOSPHATAEMIA (5 patients)
JAUNDICE (5 patients)
RESPIRATORY FAILURE (5 patients)
SOMNOLENCE (5 patients)
TACHYCARDIA (5 patients)
ABDOMINAL PAIN (4 patients)
ADVERSE DRUG REACTION (4 patients)
FALL (4 patients)
HAEMODIALYSIS (4 patients)
HAEMOGLOBIN DECREASED (4 patients)
INTESTINAL OBSTRUCTION (4 patients)
MALAISE (4 patients)
SLEEP APNOEA SYNDROME (4 patients)
SUPRAVENTRICULAR TACHYCARDIA (4 patients)
THROMBOCYTHAEMIA (4 patients)
THROMBOCYTOPENIA (4 patients)
WHITE BLOOD CELL COUNT DECREASED (4 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (3 patients)
BACTERIAL SEPSIS (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
BLOOD CREATININE INCREASED (3 patients)
DECREASED APPETITE (3 patients)
DERMATITIS EXFOLIATIVE (3 patients)
DEVICE DISLOCATION (3 patients)
ENTERITIS (3 patients)
FEBRILE NEUTROPENIA (3 patients)
FIBRIN D DIMER INCREASED (3 patients)
FUSOBACTERIUM INFECTION (3 patients)
HAEMOPTYSIS (3 patients)
HYPOXIA (3 patients)
ILEUS (3 patients)
LEUKAEMIA RECURRENT (3 patients)
MUCOSAL INFLAMMATION (3 patients)
NEUROTOXICITY (3 patients)
NEUTROPENIA (3 patients)
OVERDOSE (3 patients)
PRESYNCOPE (3 patients)
PROTEUS INFECTION (3 patients)
RASH (3 patients)
RENAL FAILURE ACUTE (3 patients)
SEPTIC SHOCK (3 patients)
SUPERINFECTION (3 patients)
TONGUE DISORDER (3 patients)
ACUTE PULMONARY OEDEMA (2 patients)
AGRANULOCYTOSIS (2 patients)
ATRIAL FIBRILLATION (2 patients)
BLOOD FIBRINOGEN INCREASED (2 patients)
BLOOD GLUCOSE INCREASED (2 patients)
BONE MARROW DEPRESSION (2 patients)
BONE MARROW FAILURE (2 patients)
BRONCHOPULMONARY ASPERGILLOSIS (2 patients)
C-REACTIVE PROTEIN INCREASED (2 patients)
CHILLS (2 patients)
COLITIS ISCHAEMIC (2 patients)
CONSTIPATION (2 patients)
CONVULSION (2 patients)
CORONARY ARTERY DISEASE (2 patients)
DEAFNESS (2 patients)
DIZZINESS (2 patients)
DRUG ADMINISTRATION ERROR (2 patients)
DYSPHAGIA (2 patients)
DYSURIA (2 patients)
EJECTION FRACTION DECREASED (2 patients)
ERYSIPELAS (2 patients)
FACIAL PALSY (2 patients)
FEBRILE BONE MARROW APLASIA (2 patients)
FLATULENCE (2 patients)
GASTROENTERITIS (2 patients)
HAEMATOCRIT DECREASED (2 patients)
HYPERSENSITIVITY (2 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (2 patients)
INFECTION (2 patients)
KLEBSIELLA SEPSIS (2 patients)
LEUKOPENIA (2 patients)
LYMPHANGITIS (2 patients)
LYMPHOCYTE COUNT INCREASED (2 patients)
NERVOUS SYSTEM DISORDER (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
OEDEMA MUCOSAL (2 patients)
OTITIS MEDIA (2 patients)
PANCYTOPENIA (2 patients)
PARTIAL SEIZURES (2 patients)
PLATELET COUNT DECREASED (2 patients)
PULMONARY EMBOLISM (2 patients)
RED BLOOD CELL COUNT DECREASED (2 patients)
RENAL FAILURE (2 patients)
RHINORRHOEA (2 patients)
SHOCK (2 patients)
STREPTOCOCCAL SEPSIS (2 patients)
SUDDEN CARDIAC DEATH (2 patients)
URTICARIA (2 patients)
ACCIDENTAL OVERDOSE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (1 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (1 patients)
AGITATION (1 patients)
ALVEOLITIS (1 patients)
ANOREXIA (1 patients)
ANXIETY (1 patients)
APHASIA (1 patients)
APHTHOUS STOMATITIS (1 patients)
ARACHNOIDITIS (1 patients)
BLOOD CULTURE POSITIVE (1 patients)
CALCULUS URINARY (1 patients)
CANDIDA SEPSIS (1 patients)
CANDIDIASIS (1 patients)
CARDIO-RESPIRATORY ARREST (1 patients)
CENTRAL NERVOUS SYSTEM LEUKAEMIA (1 patients)
CEREBRAL HAEMORRHAGE (1 patients)
CHEST PAIN (1 patients)
COLITIS (1 patients)
CONFUSIONAL STATE (1 patients)
COUGH (1 patients)
CYANOSIS (1 patients)
DIARRHOEA INFECTIOUS (1 patients)
DISEASE PROGRESSION (1 patients)
DISLOCATION OF VERTEBRA (1 patients)
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG (1 patients)
DRUG HYPERSENSITIVITY (1 patients)
DRUG TOXICITY (1 patients)
DRY SKIN (1 patients)
ENCEPHALOPATHY (1 patients)
EPILEPSY (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (1 patients)
GENERAL PHYSICAL CONDITION ABNORMAL (1 patients)
GRAFT VERSUS HOST DISEASE (1 patients)
HAEMATURIA (1 patients)
HEADACHE (1 patients)
HYPERBILIRUBINAEMIA (1 patients)
HYPERTENSIVE CRISIS (1 patients)
HYPOACUSIS (1 patients)
HYPOAESTHESIA (1 patients)
HYPOCALCAEMIA (1 patients)
HYPOMANIA (1 patients)
HYPOVOLAEMIC SHOCK (1 patients)
KLEBSIELLA INFECTION (1 patients)
LACTOSE INTOLERANCE (1 patients)
LEUKAEMIA PLASMACYTIC (1 patients)
METASTATIC NEOPLASM (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE MYELOMA (1 patients)
MUSCULAR WEAKNESS (1 patients)
MYALGIA (1 patients)
MYOGLOBIN BLOOD INCREASED (1 patients)
NEOPLASM (1 patients)
NEURALGIA (1 patients)
OEDEMA (1 patients)
OEDEMA PERIPHERAL (1 patients)
PAIN (1 patients)
PARESIS (1 patients)
PNEUMONIA KLEBSIELLA (1 patients)
PNEUMONITIS (1 patients)
PRODUCTIVE COUGH (1 patients)
PRURITUS (1 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (1 patients)
PULMONARY HYPERTENSION (1 patients)
RADIUS FRACTURE (1 patients)
RASH GENERALISED (1 patients)
RASH MACULAR (1 patients)
RASH MACULO-PAPULAR (1 patients)
RENAL COLIC (1 patients)
RESPIRATORY DISTRESS (1 patients)
RIGHT VENTRICULAR DYSFUNCTION (1 patients)
SEPSIS (1 patients)
SKIN LESION (1 patients)
SPUTUM PURULENT (1 patients)
STAPHYLOCOCCAL BACTERAEMIA (1 patients)
STEM CELL TRANSPLANT (1 patients)
STOMATITIS (1 patients)
THROMBOSIS (1 patients)
THROMBOTIC MICROANGIOPATHY (1 patients)
TOXICITY TO VARIOUS AGENTS (1 patients)
ULNA FRACTURE (1 patients)
WEIGHT DECREASED (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALIZAPRIDE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about FLATULENCE and ALIZAPRIDE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALIZAPRIDE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALIZAPRIDE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALIZAPRIDE experts. If you are a healthcare provider experienced in prescribing ALIZAPRIDE, please register here.

Your online appointment book for Sterling Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use